or Try an Advanced Search...

    ETF Components for GNOM - Global X Genomics & Biotechnology ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ALNY B 0.37 6.91
    RNA A 5.62 5.38
    NTRA B 0.19 4.90
    BNTX B 0.98 4.83
    RARE C 1.73 4.51
    TECH B -2.20 4.45
    VCYT C -2.67 4.42
    MYGN D -1.31 4.03
    QGEN D -1.45 3.93
    ILMN C -1.10 3.90
    A B -1.14 3.86
    LEGN F -2.57 3.75
    SRPT F -2.05 3.64
    NTLA F -6.57 3.46
    BEAM F -4.45 3.05
    ARWR F -0.98 3.05
    CRSP F -2.98 3.03
    TXG F -5.62 2.94
    BMRN F -0.27 2.79
    RCKT F -7.31 2.64
    CDNA C -0.96 2.62
    GILD A 0.12 2.24
    MRNA F -4.34 2.13
    VRTX D 1.01 2.08
    VIR F 0.93 1.16
    SANA F 1.92 0.91
    RGNX F -2.67 0.84
    PACB F -4.71 0.80
    FLGT F -3.04 0.74
    ALLO F -4.64 0.51
    EDIT F -4.11 0.50
    VERV F -1.03 0.48
    TSVT C -2.54 0.40
    QURE F -6.29 0.38
    PSTX D -3.85 0.38
    LYEL F -7.25 0.32
    CRBU F -6.63 0.27
    BLUE F -9.39 0.17
    SCLX F -3.85 0.06

    Represented by ETF Holdings

    Keywords: Biotechnology Life Sciences Medicine Biology Cancer Biopharmaceutical Acid Genetics Clinical Medicine Immune System Molecular Biology Disease Medical Genetics S&P 500 Applied Genetics Chimeric Antigen Receptor T Cell Gene Expression Gene Therapy Genome Genomics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - General Drug Manufacturers - Major Health Information Services

    Recent News for Global X Genomics & Biotechnology ETF & its Holdings

    Date Stock Title
    Oct 1 GILD $1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
    Oct 1 MYGN Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
    Oct 1 TXG 10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
    Oct 1 TECH Salesforce Stock Gets a Wall Street Boost, Cloud Businesses Back?
    Oct 1 TECH Apple's iPhone 16 Cycle Faces Headwinds: Analyst Warns Of Weaker Demand, Macro Pressures, Potential Early Production Cuts
    Oct 1 MRNA The Covid Era Tech Promises To Reinvent Cancer Treatment
    Oct 1 SRPT Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
    Oct 1 TECH Up 90% and Still Running: On Holding Stock's Remarkable Climb
    Oct 1 TECH Zeta Global's AI Cloud: Your Secret Weapon for Massive Growth
    Oct 1 BMRN 3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
    Oct 1 TECH Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
    Oct 1 TECH Baidu, JD In Focus As Jim Cramer Weighs In On China's Stock Stabilization Fund
    Oct 1 BMRN BMRN or MYGN: Which Is the Better Value Stock Right Now?
    Oct 1 MYGN BMRN or MYGN: Which Is the Better Value Stock Right Now?
    Oct 1 TECH Alibaba's Sun Art Faces Uncertainty as Trading Suspension Fuels Divestment Rumors: Report
    Oct 1 BNTX ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 MRNA ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 TECH Elon Musk Reacts To Bill Gates' AI Program To Ban Harmful Speech: 'Yikes'
    Oct 1 MRNA Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
    Oct 1 QGEN QIAGEN Launches QIAcuityDx Digital PCR System: Stock to Gain?
    The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Biotechnology Genomics
    Back to the Main GNOM Page...